Brief Title
Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
Protocol ID
NCT01949194
Brief Summary
Condition: Metastatic Colorectal Cancer
Intervention: Drug: Regorafenib
Sponsors: Gerald Batist; Bayer; Quebec Clinical Research Organization in Cancer
Recruiting
Intervention: Drug: Regorafenib
Sponsors: Gerald Batist; Bayer; Quebec Clinical Research Organization in Cancer
Recruiting
Pub Date:
Tuesday, September 24, 2013 - 9:00am